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Introduction
Chinese Hamster Ovary (CHO) cells are the most widely
used industrial hosts for the production of recombinant
DNA technology drugs [1]. In such processes amino acids
(a.a.) are vital nutrients for growth, but also building
blocks of the recombinant protein (rprotein). Our research
aims to establish a better understanding of a.a. transport
in and out of cells, since this could have significant impact
on increasing productivity and designing feeding strategies
during bioprocessing.
There are about 46 a.a. transporter proteins in mam-
malian cells, the genes of which are presented in Table 1
along with their substrates and all are members of the
Solute Carriers (SLC) database [2]. A.a. transporters are
subject to different expression profiles among mamma-
lian cells and are grouped into more than 18 systems,
based on sequence homology and function.
To our knowledge, there is no comprehensive study of
a.a. transporters in industrially relevant CHO cells in the
literature. To that direction, a.a. transporter genes were
profiled during batch culture of three CHO cell lines
with varying levels of productivity. In parallel, the intra-
and extracellular levels of a.a. were quantified.
Materials and methods
Three cell lines were kindly donated by Lonza Biologics.
GSn8 cell line was transfected with an empty glutamine
synthetase (GS) vector. GS35 and GS46 cell lines were
both transfected with a GS vector that also carries
the heavy and light chains of a chimeric IgG4 antibody.
The specific productivity of cell line GS46, quantified by a
commercial ELISA kit (Bethyl laboratories, US), is approxi-
mately double that of GS35 one.
Batch cultures were performed in triplicate in 1L Erlen-
meyer flasks with a working volume of 300mL in CD-
CHO medium (Invitrogen, UK) supplemented with 25 μM
MSX (Sigma, UK). Viable cell concentration was deter-
mined daily using the trypan blue dye exclusion method.
40 a.a. transporters were studied in all cell lines using
real time quantitative reverse transcription polymerase
chain reaction on samples from different phases of batch
culture. Samples were collected at day 4 (exponential
phase) and day 6 & day 7 (stationary phase) of the growth
curve for all cell lines (samples were also taken at day 3
for IgG4 producers only and day 9 for the null cell line
only). Results are reported against the housekeeping gene
“actb”. Housekeeping genes “vezt” and “hirip3” were also
well correlated.
The extracellular and intracellular a.a. profiles were
monitored daily using high performance liquid chromato-
graphy (PicoTag, Waters, UK). Intracellular samples were
quenched with 0.9% w/v NaCl and extracted with a 50%
aqueous acetonitrile solution, as described in [3].
Results
The results (Table 1) reveal that ~30% of transporters are
lowly expressed (fractional copies per cell), 9% are below
levels of detection, whereas 40% are significantly differen-
tially expressed either during batch cell culture, or
between cell lines, or both. The remaining transporters
appear to remain stable.
Regulation within culture
The majority of the transporters are found to be upregu-
lated at stationary phase for all cell lines, as also presented
in Figure 1, where a mapping of a.a. metabolism and trans-
port has been illustrated for the null cell line. Specifically,
five genes encoding for transporters of a.a. relating to the
glutathione (GSH) pathway were found to be upregulated
significantly higher than 2 fold at stationary phase, when
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compared to exponential phase for all cell lines. These
genes were: slc1a4 (Ala and Cys), slc6a9 (Gly), slc1a2 (Glu
and Asp), slc7a11 (Cystine and Glu), and heteromeric
transporter slc3a2 which partners with slc7a11. GSH is a
well-known marker of oxidative stress [4], high levels of
which have been associated with high productivity [5].
Regulation between cell lines
In their majority, genes were found to be upregulated for
protein producing cell lines at all time points. Genes
whose expression is upregulated significantly (two-fold or
higher) in the protein-producers at all time points
analyzed were: slc43a2 (system L, leucine and branched-
chain a.a.) and slc1a2 (system X-AG, glutamate and aspar-
tate). However, no genes, apart from slc6a6 (taurine and
b-Ala), were found to be differentially expressed between
high (GS46) and low producer (GS35). We find slc6a6
gene differentially expressed early in cell culture (day 3),
which makes us hypothesize that the gene could be a
candidate for selection purposes. The overexpression of
Table 1 Amino acid transporter genes based on the SLC database [2].
System GENES Substrates Expresion/ Type
of regulation
System GENES Substrates Expresion/ Type
of regulation




PAT SLC36a1 Gly, Ala, Pro, b- Ala,
Tau
remains stable
SLC38a2 Ala, Asn, Cys, Gln, Gly,
His, Met, Pro, Ser
between cell linesb SLC36a2 Gly, Ala, Pro lowa
SLC38a4 Ala, Asn, Cys, Gly, Ser,
Thr
within cell culturec SLC36a3 putative lowa
ASC SLC1a4 Ala, Ser, Cys, Thr within cell culturec SLC36a4 Ala, Pro, Trp remains stable
SLC1a5 Ala, Ser, Cys, Thr, Gln,
Asn
bothd T SLC16a10 Phe, Tyr, Trp lowa
asc SLC7a10/
SLC3a2
Ala, Cys, Gly, Ser, Thr lowa X-AG SLC1a1 Asp, Glu low
a
B0 SLC6a19 Pro, Leu, Val, Ile, Met lowa SLC1a2 Asp, Glu bothd
SLC6a15 Pro, Leu, Val, Ile, Met remains stable SLC1a3 Asp, Glu between cell linesb




Arg, Lys, Cystine lowa SLC1a7 Asp, Glu below detection
limits
b SLC6a6 Tau, b-Ala bothd x-c SLC7a11/
SLC3a2
Glu, Cystine within cell culturec
Gly SLC6a9 Gly within cell culturec y+ SLC7a1 Arg, Lys, His bothd
SLC6a5 Gly lowa SLC7a2 Arg, Lys, His lowa
SLC6a18 Gly below detection
limits
SLC7a3 Arg, Lys, His lowa
IMINO SLC6a20 Pro lowa y+L SLC7a7/
SLC3a2





Cys, Leu, Phe, Trp, Val,
Tyr, Ile, His, Met
bothd SLC7a6/
SLC3a2





neutral a.a., except Pro lowa His & small
peptides
SLC15a3 His between cell linesb
SLC43a1 Leu, Ile, Met, Phe lowa SLC15a4 His between cell linesb
SLC43a2 Leu, Ile, Met, Phe between cell linesb Heavy subunits of
hetero-meric
SLC3a1 various based on
“partner”
lowa
SLC43a3 putative between cell linesb SLC3a2 various based on
“partner”
bothd
N SLC38a3 Ala, Asn, Gln, His not checked Not in a system SLC6a7 Pro not checked
SLC38a5 Gln, Asn, His, Ser bothd SLC6a17 neutral a.a. not checked
SLC7a13 Asp, Glu not checked
SLC12A8 putative not checked
The “Expression/ Type of regulation” column refers to our results for the CHO cell lines described in the materials & methods section: alow levels-refers to
fractional copies per cell; bregulation between cell lines-refers to regulation significantly higher than two fold at least at a time point between the different cell
lines presented; cregulation within cell culture-refers to differential expression (significantly higher than two fold) at least at a time point within cell culture of a
given cell line; dboth types of regulation-refers to a gene presenting both b and c as discussed previously.
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this gene in CHO cells has been found to significantly
enhance growth and productivity [6].
Feeding strategy based on order of feeding
The a.a. transporters gene expression findings correlate
well with the extracellular and intracellular concentration
profiles of their respective substrates (Figure 1). By ana-
lysing the differentially expressed genes for a specific cell
line a feeding strategy can be designed. For example, we
find transporter slc7a5, of system L, highly upregulated at
stationary phase for the null cell line (Figure 1). This
transporter exchanges an intracellular neutral a.a. with
an extracellular branched chain one (isoleucine, leucine,
valine). Branched chain amino acids are associated with
the mTor signalling pathway, essential regulator for
many physiological roles in mammalian cells [7]. Hence,
a feeding strategy can be proposed, where neutral amino
acids are fed first and followed by branched chain amino
acids, in order for them to be more effectively uptaken. A
similar type of pre-conditioning was found to signifi-
cantly enhance cellular protein production in another
type of mammalian cells [7].
Conclusions
Glutathione pathway associated a.a. transporters (slc1a2,
slc1a4, slc6a9, slc7a11/ slc3a2) can be targeted as genetic
engineering targets, since are all found highly upregu-
lated at stationary phase of cell culture. Additionally,
Figure 1 A map associating the differentially expressed amino acid transporters for the null cell line, their amino acid substrates, and
the intracellular concentrations (femtomol/ cell, in the area designated by the “IN” tag) and extracellular concentrations (mM, in the
area designated by the “OUT” tag) of the latter. A.a. transport is highlighted by the black box. The expression of the mRNA levels of the
differentially expressed a.a. transporters (in mRNA copies per cell) at different phases of cell culture, exponential (day 4), stationary (days 6 & 7),
and decline (day 9) is displayed at the bottom, where stationary phase samples are averaged, since not statistically different (for ease of statistical
analysis visualization). The relevant energy utilisation mechanisms of each system are also depicted (top). Genes: slc6a9 (glycine), slc1a2 (acidic a.
a.), slc7a7 (basic and branched chain a.a.) and its heteromeric transporter slc3a2 were also found to be differentially expressed, but are not
presented in this figure. Our chosen a.a. analysis method was not able to quantify cysteine (L-Cys) levels.
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transporters slc1a2, slc43a2 are associated with rprotein
productivity, since all of them are found to be upregu-
lated for producing cell lines vs the null. Gene slc6a6,
carrying taurine and b-alanine, can be associated with
high productivity (as also suggested in [6]), as was also
found to be differentially expressed in the high vs the low
producer early in cell culture. A feeding strategy can be
proposed, based on our results that remains to be tested
experimentally. Finally, extending this integrative
approach to the proteome level would help link regula-
tion at the transcriptomic level to actual differences in
transport capability.
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